Physician profile
Jay K Patel
NPI 1801874045
$11,491.16
in general payments reported to CMS, 2019-2025
48 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,269 · 2020: $821 · 2021: $1,445 · 2022: $1,460 · 2023: $2,203 · 2024: $1,886 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,399 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,398.51 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,404.01 | 2019-2023 | Xarelto |
| Amgen INC. | $1,050.06 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $820.18 | 2019-2025 | Watchman Flx, Watchman, Avvigo Guidance System |
| Astrazeneca Pharmaceuticals LP | $818.40 | 2019-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $662.25 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Medtronic, INC. | $600.48 | 2021-2025 | Onyx Frontier, Symplicity G3, Cobalt Dr Mri Surescan |
| Shockwave Medical, INC | $596.61 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $558.42 | 2019-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $544.25 | 2019-2023 | Xience Skypoint, Perclose Prostyle |
| Novartis Pharmaceuticals Corporation | $504.46 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $450.26 | 2022-2025 | Assure Wcd |
| Terumo Medical Corporation | $339.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $290.88 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $251.09 | 2024 | Optimizer |
| Novo Nordisk INC | $244.34 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.